<DOC>
	<DOCNO>NCT00034268</DOCNO>
	<brief_summary>The purpose study determine : 1 . If treatment LY900003 plus gemcitabine cisplatin help live long , compare gemcitabine cisplatin alone . 2 . The safety LY900003 plus gemcitabine cisplatin side effect might associate combination three drug . 3 . Whether LY900003 plus gemcitabine cisplatin make tumor small disappear , long , compare gemcitabine cisplatin alone . It possible information collect study analyze sponsor future evaluate LY900003 plus gemcitabine cisplatin possible use medical scientific purpose currently propose . LY900003 may add benefit gemcitabine plus cisplatin .</brief_summary>
	<brief_title>A Phase 3 Trial LY900003 Plus Gemcitabine Cisplatin Versus Gemcitabine Cisplatin Patients With Advanced , Previously Untreated Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Stage IIIB IV nonsmall lung cancer 2 . Able visit doctor 's office 3 . At least 18 year age 4 . Adequate kidney , adrenal , liver function 1 . Prior chemotherapy biologic therapy NSCLC 2 . Central nervous system tumor 3 . Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>Stage IIIB IV non-small cell lung cancer ( NSCLC )</keyword>
</DOC>